Dr Åslaug Helland, of Oslo University Hospital speaks about IMPRESS Norway

Dr Åslaug Helland, of Oslo University Hospital, joined us for our panel discussion on February 4 to discuss, ‘Innovative Clinical Trial Design for Precision Oncology’.

“Our main aim is to implement precision medicine in cancer in Norway.”

If you would like to watch the full discussion, and register for future events, click here.

Please feel free to share this...